Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
<BR>
https://www.nejm.org/doi/full/10.1056/NEJMoa1711948
<BR>
Authors’ Conclusions: “Oral edoxaban was noninferior to subcutaneous dalteparin
Source: thesgem.com
0 0 78
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
https://www.nejm.org/doi/full/10.10
Authors’ Conclusions: “Oral edoxaban was noninferior to subcutaneous dalteparin with respect to the composite outcome of recurrent venous thromboembolism or major bleeding. The rate of recurrent venous thromboembolism was lower but the rate of major bleeding was higher with edoxaban than with dalteparin.”
SGEM: Our conclusion would have been “oral edoxaban had a higher rate of clinically relevant bleeding compared to dalteparin, was noninferior with respect to recurrent VTE and no statistically significant different was observed in all-cause mortality and event-free survival.”
- Visual Abstract by hellomynameisDrKirsty @KirstyChallen
#Edoxaban #Cancer #VenousThromboembolism #VTE #EBM #VisualAbstract #DVT #PE
More like this
Practice Guidelines for Preoperative Fasting
<BR>
Infographic by Dr. Jesse Burk-Rafel
@jbrafel
<BR>
> 8 hours - Heavy foods (fried/fatty) and Spironolactone Versus Clonidine as a Fourth-Drug Therapy for Resistant Hypertension: The ReHOT Randomized Study (Resistant Hypertension Lower Extremity Venous Thrombosis - Management and Anatomy
<BR>
Deep - Superficial - Active Bleeding
<BR>
#LowerExtremity #Veins #Venous #Thrombosis Upper Extremity Venous Thrombosis - Management and Anatomy
<BR>
Deep - Superficial - Catheter Associated
<BR>
#UpperExtremity #Veins #Venous #Thrombosis Transfusion strategies for acute upper gastrointestinal bleeding - Visual Abstract
<BR>
Villanueva Cetal. NEJM 2013 PMID 23281973 https://www.ncbi.nlm.nih.gov/pubmed/23281973
<BR>
Oral anticoagulant dosing and bridging for VTE
<BR>
- Dr. Joseph Shatzel @Clotmaster 
<BR>
#VTE #DOAC #Bridging #Dosing #Oral